Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 43Neoplasm Metastasis 5Neoplasms 4Ovarian Neoplasms 3Hereditary Sensory and Autonomic Neuropathies 3Carcinoma, Non-Small-Cell Lung 3Endometrial Neoplasms 2Carcinoma, Ovarian Epithelial 2Breast Cancer Metastatic 2Advanced Breast Cancer 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Lymphoma, Non-Hodgkin 1Hyperglycemia 1HER2-positive Metastatic Breast Cancer 1HER2-positive Breast Cancer 1Female Breast Carcinoma 1Exanthema 1Carcinosarcoma 1Carcinoma, Lobular 1Breast Neoplasms, Male 1Anatomic Stage IV Breast Cancer AJCC v8 1Adenocarcinoma Of Esophagus 1

Interventions

Radiotherapy 11Fluorouracil 8Cisplatin 6Oxaliplatin 5Carboplatin 5Paclitaxel 4Neoadjuvant Therapy 4Leucovorin 4Gefitinib 4pembrolizumab 3Radiation 3Irinotecan 3Taxes 2Surgical Procedures, Operative 2Gemcitabine 2Docetaxel 2Cetuximab 2130-nm albumin-bound paclitaxel 2vandetanib 1spartalizumab 1sargramostim 1romidepsin 1ribociclib 1regorafenib 1oblimersen 1incomplete Freund's adjuvant 1fish oil triglycerides 1dehydroftorafur 1ceritinib 1benzamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Adenocarcinoma Of Esophagus × Fulvestrant × Clear all
NCT05252416 2025-11-28

(VELA) Study of BLU-222 in Advanced Solid Tumors

Blueprint Medicines Corporation

Phase 1 Terminated
50 enrolled
GastrointestinalGynecologicSarcoma

Adenocarcinoma Of Esophagus, Carcinosarcoma, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡